Neoplastic Processes  >>  Xcytrin (motexafin gadolinum)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Xcytrin (motexafin gadolinum) / AbbVie
NCT00003563: Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases

Completed
3
430
US, Canada
WBRT, MGd, MGd plus WBRT
Pharmacyclics LLC.
Metastatic Cancer
09/01
06/05
NCT00054795: Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Completed
3
550
US, Canada, Europe, RoW
Motexafin Gadolinium
Pharmacyclics LLC.
Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Metastases, Neoplasm
 
 

Download Options